Picture Demy-Colton BioFuture 2021 NYC C Virtual Option 650x80px
Document › Details

Evotec AG. (3/28/17). "Press Release: Evotec Fiscal Year Results 2016. Leading Innovation Efficiency and First-in-class Drug Discovery". Hamburg.

Organisations Organisation Evotec AG (FSE: EVT, TecDAX)
  Today Evotec SE (FSE: EVT, MDA X/TecDAX)
  Group Evotec (Group)
  Organisation 2 Topas Therapeutics GmbH
Products Product drug discovery services
  Product 2 EVT 201
Index terms Index term Cyprotex–Evotec: investment, 201610–201612 acquisition £55.7m=€66.3m in cash for all 26.1m shares + funding of all debt
  Index term 2 Evotec–Novo Group: investment, 201702 strategic investment of €90.3m 13.15m new Evotec shares at €6.87/share resulting in 8.9% ownership by Novo A/S

Record changed: 2017-04-19


Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Evotec (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group Global Partnering Four Events One Price 650x80

» top